Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

This study has been completed.
Sponsor:
Collaborator:
Biomeasure Inc, Ipsen Group
Information provided by:
Octagen Corporation
ClinicalTrials.gov Identifier:
NCT00245245
First received: October 25, 2005
Last updated: October 2, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given